Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $29.70, but opened at $28.80. Otsuka shares last traded at $28.80, with a volume of 1,309 shares.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded shares of Otsuka from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, the company has a consensus rating of “Strong Buy”.
Get Our Latest Stock Report on Otsuka
Otsuka Stock Performance
About Otsuka
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
Featured Articles
- Five stocks we like better than Otsuka
- The Fed Pivot Signal Smart Money’s Been Waiting For
- Do not delete, read immediately
- A month before the crash
- How Long Will $1M Last in Retirement?
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
